Ausgabe 2/2020
Inhalt (26 Artikel)
Anastrozole plus fulvestrant vs. anastrozole alone for hormone receptor-positive advanced breast cancer: a meta-analysis of randomized controlled trials
Meng Li, Yiting Xiong, Chen Liao, Yunyan He, Sijia Duan, Fengming Yi, Yiping Wei, Wenxiong Zhang
Management of brain metastases in breast cancer: a review of current practices and emerging treatments
Matthew N. Mills, Nicholas B. Figura, John A. Arrington, Hsiang-Hsuan Michael Yu, Arnold B. Etame, Michael A. Vogelbaum, Hatem Soliman, Brian J. Czerniecki, Peter A. Forsyth, Hyo S. Han, Kamran A. Ahmed
Oncologic safety of immediate autologous fat grafting for reconstruction in breast-conserving surgery
Camile Cesa Stumpf, Ângela Erguy Zucatto, José Antônio Crespo Cavalheiro, Marcia Portela de Melo, Rodrigo Cericato, Andréa Pires Souto Damin, Jorge Villanova Biazús
Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer
Xiao-Long Qian, Peng Xu, Yi-Qian Zhang, Yuan-Ming Song, Ya-Qing Li, Wei-Dong Li, Cheng-Ying Jiang, Bei-Bei Shen, Xin-Min Zhang, Li-Na Zhang, Li Fu, Xiao-Jing Guo
Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
Aidan C. Li, Jing Zhao, Chao Zhao, Zhongliang Ma, Ramon Hartage, Yunxiang Zhang, Xiaoxian Li, Anil V. Parwani
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer
Tomoko Shibayama, Siew-Kee Low, Makiko Ono, Takayuki Kobayashi, Kokoro Kobayashi, Ippei Fukada, Yoshinori Ito, Takayuki Ueno, Shinji Ohno, Yusuke Nakamura, Shunji Takahashi
The role of Micro-CT in imaging breast cancer specimens
Daniel DiCorpo, Ankur Tiwari, Rong Tang, Molly Griffin, Owen Aftreth, Pinky Bautista, Kevin Hughes, Neil Gershenfeld, James Michaelson
GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models
Shanchun Guo, Changde Zhang, Madhusoodanan Mottamal, Ahamed Hossain, Jiawang Liu, Guangdi Wang
Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers
Dominique Yuan Bin Seow, Joe Poh Sheng Yeong, Johnathan Xiande Lim, Noel Chia, Jeffrey Chun Tatt Lim, Clara Chong Hui Ong, Puay Hoon Tan, Jabed Iqbal
pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1
MingMing Yu, YueHua Chen, ZhenGuang Wang, XiaoDong Ding
Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity
Charlotte Rypens, Melike Marsan, Christophe Van Berckelaer, Charlotte Billiet, Kirsten Melis, Sara Perez Lopez, Peter van Dam, Gayathri R. Devi, Pascal Finetti, Naoto T. Ueno, François Bertucci, Piet Dirix, Patrick Neven, Peter Vermeulen, Luc Dirix, Steven J. Van Laere
Three-dimensional microanatomy of human nipple visualized by X-ray dark-field computed tomography
Naoki Sunaguchi, Daisuke Shimao, Tetsuya Yuasa, Shu Ichihara, Rieko Nishimura, Risa Oshima, Aya Watanabe, Kikuko Niwa, Masami Ando
Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging
Vishwa S. Parekh, Michael A. Jacobs
Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial
Xiao Sun, Xue-Er Wang, Zhao-Peng Zhang, Zhi-Qiang Shi, Bin-Bin Cong, Yong-Sheng Wang, Zhi-Min Shao
Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations
Matthew S. Katz, Linda McCall, Karla Ballman, Reshma Jagsi, Bruce G. Haffty, Armando E. Giuliano
Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women
Erin Linnenbringer, Arline T. Geronimus, Kia L. Davis, John Bound, Libby Ellis, Scarlett L. Gomez
Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence
Jingjing Zhu, Fei Wang, Liang Shi, Hui Cai, Ying Zheng, Wei Zheng, Pingping Bao, Xiao-Ou Shu
The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society
Hyung Suk Kim, Tae Kyung Yoo, Woo Chan Park, Byung Joo Chae
Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database
Samuel Sarmiento, Michael McColl, Leila Musavi, Faiz Gani, Joseph K. Canner, Lisa Jacobs, Fanmeng Fu, Charalampos Siotos, Mehran Habibi
Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017
Zhilin Chen, Lu Xu, Wenjie Shi, Fanyu Zeng, Rui Zhuo, Xinbao Hao, Pingming Fan
Trend and survival benefit of Oncotype DX use among female hormone receptor-positive breast cancer patients in 17 SEER registries, 2004–2015
Lu Zhang, Mei-Chin Hsieh, Valentina Petkov, Qingzhao Yu, Yu-wen Chiu, Xiao-Cheng Wu
High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
Irene Rainville, Shanell Hatcher, Eric Rosenthal, Katie Larson, Ryan Bernhisel, Stephanie Meek, Heidi Gorringe, Erin Mundt, Susan Manley
The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1)
Steven Sorscher, Katherine Ansley, Steven Douglas Delaney, Shakti Ramkissoon
High serum levels of periostin are associated with a poor survival in breast cancer
Tilman D. Rachner, Andy Göbel, Oliver Hoffmann, Kati Erdmann, Sabine Kasimir-Bauer, Dorit Breining, Rainer Kimmig, Lorenz C. Hofbauer, Ann-Kathrin Bittner